Latest Articles

Technology Networks caught up with Dr. Anne Carpenter at ELRIG Drug Discovery 2024 to learn more about the Cell Painting assay and its impact on the pharmaceutical industry.

In laboratory tests, bioactive glasses doped with gallium oxide killed more than 99% of osteosarcoma cells, while leaving healthy human osteoblasts unharmed. This could one day form the basis of new bone cancer treatments, researchers say.

Single-cell analysis offers a unique perspective of the genetic and molecular features of individual cells. In this article, two early adopters of single-cell analysis technologies highlight some of the latest advances and new applications.

This article examines how next-generation sequencing and state-of-the-art imaging technologies are being combined to characterize and map the spatial organization of cell types in tissues.

Researchers investigated the ability of metformin to protect human cells and mice from DNA damage due to radiation exposure. If successfully repurposed, the drug has the potential to help at-risk groups, such as cancer patients and astronauts.

Technology Networks spoke to Max Jamilly, co-founder of Hoxton Farms, to hear how the company plans to fatten up the plant-based "meat" market.

We spoke to physician–scientist Professor Pradipta Ghosh about what drove her to follow this career path, her current work, the value of and challenges faced by physician–scientists and advice for those who are considering following in her footsteps.

In this interview, we spoke to Dr. Raquel Cuella Martin to learn about her research, her experiences working as an LGBTQIA+ researcher in STEMM and her advice for others beginning a STEMM career.

Dr. Stephen Robinson reflects on his career, LGBTQIA+ identity and mentorship. He emphasizes the importance of authenticity, visibility, and supporting the next generation of scientists in their unique paths.

In this interview, Avery Cunningham discusses the creation of STEM, LGBTQ & You, his experiences as a queer person in STEMM and the barriers that face LGBTQ+ individuals in the field.